Acute Lymphoblastic Leukaemia: ALLTogether Treatment Study

We are studying new treatment options for children and young adults aged 0-45 with newly diagnosed acute lymphoblastic leukaemia. The goal is to improve survival and quality of life through various interventions.

>2 years Efficacy phase (II)Confirmation phase (III)No Placebo Standard Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Besponsa

Besponsa is a medicine used to treat certain relapsed or hard‑to‑treat acute lymphoblastic leukemia, a type of blood cancer.

Blincyto

Blincyto is a cancer medicine used to treat certain types of acute lymphoblastic leukemia by helping the immune system target leukemia cells.

Cytarabine

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Blinatumomab

Blinatumomab is a substance that directs the immune system to attack certain leukemia cells, used for treating some types of acute lymphoblastic leukemia.

Cytarabine

Cytarabine is a chemotherapy substance used to treat certain blood cancers, especially acute leukemias.

Dexamethasone

Dexamethasone is a steroid that reduces inflammation and suppresses the immune system to treat allergic, inflammatory, and autoimmune conditions.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Alexan

Ara-Cell

Aracytin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

UZ Leuven

Pediatric hematology and oncology

Heverlee, Belgium

Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola

Pediatric hematology and oncology

Jette, Belgium

Universitair Ziekenhuis Gent

Pediatric hematology and oncology

Ledeberg, Belgium

Sponsor: Karolinska University Hospital

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.